Register now to attend the Accelerating Anticancer Agent Development and Validation Workshop May 4-6, 2016, at Bethesda North Marriott Hotel and Conference Center in Bethesda, Md.
AAADV is the only workshop held in collaboration with the U.S. Food and Drug Administration designed specifically to help participants understand and negotiate the drug development approval process so that effective new cancer treatments can reach patients more quickly.
New in 2016: Two pre-Workshop courses (May 3) cover the basics of drug development
AAADV Scholars for Clinical and Translational Investigators
AAADV Fundamentals for Patient Advocates
Two pre-Workshop training courses – AAADV Scholars and AAADV Fundamentals – will cover the basics of oncology drug development, preparing scientists and advocates to benefit more fully from Workshop sessions. A limited number of registration and travel scholarships are available for early-career academics and patient advocates.
Workshop Participants will:
Examine the most urgent issues and meaningful trends in anticancer agent development and validation.
Learn new approaches for diagnosing, treating and preventing cancer.
Benefit from a mix of small group lectures, moderated discussions, facilitated case studies of successful new drug applications and plenary lectures.
Network with researchers, regulators, patient advocates and others working on the frontlines of cancer research and treatment.
Who Should Attend:
· Scientists with clinical trial experience interested in developing agents for the diagnosis, treatment or prevention of cancer
· Patient advocates involved in the clinical trial process
U.S. Food and Drug Administration
Accelerate Brain Cancer Cure
Susan G. Komen
American Association for Cancer Research
American Society of Clinical Oncology